HA
Hansa Biopharma
Latest price
32.08 SEK
22/07/2026
Latest
36.00 SEK
+12.22%
Upside
3 mo
44.50 SEK
+38.72%
Upside
HNSA
3 mo+38.72%2 price targets
6 mo+38.72%2 price targets
1 yr+159.51%8 price targets
Max 8 price targets
DNB CarnegieDanske Bank
HealthcareBiotechnology
About The Company
Hansa Biopharma AB is a Swedish biopharmaceutical company developing immunomodulatory enzyme treatments for rare immunological conditions. The company focuses on developing treatments for organ transplantation and autoimmune diseases.
Wikipedia
Three Month Consensus
Consensus
44.50 SEK
Upside
+38.72%
Latest price32.08 SEK
Insider Trades for Hansa Biopharma
No insider trades for the selected period.
